Figures computed from official regulatory filings — .
Analysttarget 37.33 USD (+35%) · consensus 5/5 · 7 buy · 0 hold · 0 sell
Ownershipinsiders 40.13% · institutions 41.41% · short 3.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for BIODESIX INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
84 buys134 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| PATIENCE JOHNtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PATIENCE JOHNtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| SCHULER JACK Wtrack record | Buy | $367K | conv 18 | SEC |
| SCHULER JACK Wtrack record | Buy | $337K | conv 20 | SEC |
| SCHULER JACK Wtrack record | Buy | $328.9K | conv 18 | SEC |
| PATIENCE JOHNtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| PATIENCE JOHNtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PATIENCE JOHNtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| PATIENCE JOHNtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| O'Kane Kieran | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Hutton Scott | Sell | $19K | SEC |
| Pestano Gary Anthony | Sell | $7.1K | SEC |
| Hutton Scott | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Cowie Robin Harper | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Hutton Scott | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pestano Gary Anthony | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Vazquez Chris | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Vazquez Chris | Exercise | n/a (No price was disclosed in the filing) | SEC |
| O'Kane Kieran | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cowie Robin Harper | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Vazquez Chris | Sell | $2.7K | Unusual size | SEC |
| Cowie Robin Harper | Sell | $6.8K | SEC |
| O'Kane Kieran | Sell | $6.8K | SEC |
| Pestano Gary Anthony | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pestano Gary Anthony | Sell | $5.4K | SEC |